Factors that have an Impact on Abbreviated New Drug Application (ANDA) Submissions.

MLA

Wittayanukorn, Saranrat, et al. “Factors That Have an Impact on Abbreviated New Drug Application (ANDA) Submissions.” Therapeutic Innovation & Regulatory Science, vol. 54, no. 6, Nov. 2020, pp. 1372–81. EBSCOhost, https://doi.org/10.1007/s43441-020-00163-x.

APA

Wittayanukorn, S., Rosenberg, M., Schick, A., Hu, M., Wang, Z., Babiskin, A., Lionberger, R., & Zhao, L. (2020). Factors that have an Impact on Abbreviated New Drug Application (ANDA) Submissions. Therapeutic Innovation & Regulatory Science, 54(6), 1372–1381. https://doi.org/10.1007/s43441-020-00163-x

Chicago

Wittayanukorn, Saranrat, Matthew Rosenberg, Andreas Schick, Meng Hu, Zhong Wang, Andrew Babiskin, Robert Lionberger, and Liang Zhao. 2020. “Factors That Have an Impact on Abbreviated New Drug Application (ANDA) Submissions.” Therapeutic Innovation & Regulatory Science 54 (6): 1372–81. doi:10.1007/s43441-020-00163-x.